Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer

por Dyar, Stephen, Moreno-Aspitia, Alvaro
Publicado 2011

Current strategies for the prevention of breast cancer

por Advani, Pooja, Moreno-Aspitia, Alvaro
Publicado 2014

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

por Advani, Pooja, Cornell, Lauren, Chumsri, Saranya, Moreno-Aspitia, Alvaro
Publicado 2015

Rifaximin for Pertuzumab-Related GI Toxicities

por Soyano, Aixa E., Reynolds, Gina, Moreno-Aspitia, Alvaro, Chumsri, Saranya
Publicado 2017

Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect

por Majeed, Umair, Puiu, Tudor, Sluzevich, Jason, Reynolds, Gina, Acampora, Marites, Moreno-Aspitia, Alvaro, Bodiford, Katherine J., Advani, Pooja
Publicado 2021

Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases

por Jaeckle, Kurt A., Dixon, Jesse G., Anderson, Stephen Keith, Moreno‐Aspitia, Alvaro, Colon‐Otero, Gerardo, Hebenstreit, Kathy, Patel, Tejal A., Reddy, Samarth L., Perez, Edith A.
Publicado 2020

Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race

por Berrian, Jennifer, Liu, Ying, Ezenwajiaku, Nkiruka, Moreno‐Aspitia, Alvaro, Holton, Sara J., Toriola, Adetunji T., Colditz, Graham A., Housten, Ashley J., Hall, Lannis, Fiala, Mark A., Ademuyiwa, Foluso O.
Publicado 2022

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)

por Sideras, Kostandinos, Hillman, David W, Giridhar, Karthik, Ginos, Brenda F, Tenglin, Richard C, Liu, Heshan, Chen, Beiyun, Tan, Winston, Gross, Gerald G, Mowat, Rex B, Dueck, Amylou C, Perez, Edith A, Moreno-Aspitia, Alvaro
Publicado 2022

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low–Expressing Advanced Breast Cancer: Results From a Phase Ib Study

por Modi, Shanu, Park, Haeseong, Murthy, Rashmi K., Iwata, Hiroji, Tamura, Kenji, Tsurutani, Junji, Moreno-Aspitia, Alvaro, Doi, Toshihiko, Sagara, Yasuaki, Redfern, Charles, Krop, Ian E., Lee, Caleb, Fujisaki, Yoshihiko, Sugihara, Masahiro, Zhang, Lin, Shahidi, Javad, Takahashi, Shunji
Publicado 2020

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

por Eiger, Daniel, Pondé, Noam F., Agbor-Tarh, Dominique, Moreno-Aspitia, Alvaro, Piccart, Martine, Hilbers, Florentine S., Werner, Olena, Chumsri, Saranya, Dueck, Amylou, Kroep, Judith R., Gomez, Henry, Láng, István, Rodeheffer, Richard J., Ewer, Michael S., Suter, Thomas, de Azambuja, Evandro
Publicado 2020

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial

por Lambertini, Matteo, Agbor-Tarh, Dominique, Metzger-Filho, Otto, Ponde, Noam F, Poggio, Francesca, Hilbers, Florentine S, Korde, Larissa A, Chumsri, Saranya, Werner, Olena, Del Mastro, Lucia, Caparica, Rafael, Moebus, Volker, Moreno-Aspitia, Alvaro, Piccart, Martine J, de Azambuja, Evandro
Publicado 2020

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

por Moreno-Aspitia, Alvaro, Dueck, Amylou C., Ghanem-Cañete, Ismael, Patel, Tejal, Dakhil, Shaker, Johnson, David, Franco, Sandra, Kahanic, Stephen, Colon-Otero, Gerardo, Tenner, Kathleen S., Rodeheffer, Richard, McCullough, Ann E., Jenkins, Robert B., Palmieri, Frances M., Northfelt, Donald, Perez, Edith A.
Publicado 2013

Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors

por Norton, Nadine, Advani, Pooja P., Serie, Daniel J., Geiger, Xochiquetzal J., Necela, Brian M., Axenfeld, Bianca C., Kachergus, Jennifer M., Feathers, Ryan W., Carr, Jennifer M., Crook, Julia E., Moreno-Aspitia, Alvaro, Anastasiadis, Panos Z., Perez, Edith A., Thompson, E. Aubrey
Publicado 2016

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

por Agostinetto, Elisa, Ameye, Lieveke, Martel, Samuel, Aftimos, Philippe, Pondé, Noam, Maurer, Christian, El-Abed, Sarra, Wang, Yingbo, Vicente, Malou, Chumsri, Saranya, Bliss, Judith, Kroep, Judith, Colleoni, Marco, Petrelli, Fausto, Del Mastro, Lucia, Moreno-Aspitia, Alvaro, Piccart, Martine, Paesmans, Marianne, de Azambuja, Evandro, Lambertini, Matteo
Publicado 2022

Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

por Cortés, Javier, Rugo, Hope S., Awada, Ahmad, Twelves, Chris, Perez, Edith A., Im, Seock–Ah, Gómez-Pardo, Patricia, Schwartzberg, Lee S., Diéras, Veronique, Yardley, Denise A., Potter, David A., Mailliez, Audrey, Moreno-Aspitia, Alvaro, Ahn, Jin-Seok, Zhao, Carol, Hoch, Ute, Tagliaferri, Mary, Hannah, Alison L., O’Shaughnessy, Joyce
Publicado 2017

Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients

por Chumsri, Saranya, Advani, Pooja P., Pai, Tanmayi S., Li, Zhuo, Mummareddy, Ashita, Acampora, Marites, Reynolds, Gina A., Wylie, Natasha, Boyle, Ashton W., Lou, Yanyan, Mody, Kabir, Moreno-Aspitia, Alvaro, Swift, Melanie D., Virk, Abinash, Bharucha, Adil E., Marquez, Christopher P., Patel, Tushar C., Gores, Gregory J., Knutson, Keith L.
Publicado 2021

Correction: Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

por Necela, Brian M., Crozier, Jennifer A., Andorfer, Cathy A., Lewis-Tuffin, Laura, Kachergus, Jennifer M., Geiger, Xochiquetzal J., Kalari, Krishna R., Serie, Daniel J., Sun, Zhifu, Moreno-Aspitia, Alvaro, O’Shannessy, Daniel J., Maltzman, Julia D., McCullough, Ann E., Pockaj, Barbara A., Cunliffe, Heather E., Ballman, Karla V., Thompson, E. Aubrey, Perez, Edith A.
Publicado 2015

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

por Dudenkov, Tanda M., Liu, Duan, Cairns, Junmei, Devarajan, Sandhya, Zhuang, Yongxian, Ingle, James N., Buzdar, Aman U., Robson, Mark E., Kubo, Michiaki, Batzler, Anthony, Barman, Poulami, Jenkins, Gregory D., Carlson, Erin E., Goetz, Matthew P., Northfelt, Donald W., Moreno‐Aspitia, Alvaro, Desta, Zeruesenay, Reid, Joel M., Kalari, Krishna R., Wang, Liewei, Weinshilboum, Richard M.
Publicado 2019

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

por Goetz, Matthew P., Kalari, Krishna R., Suman, Vera J., Moyer, Ann M., Yu, Jia, Visscher, Daniel W., Dockter, Travis J., Vedell, Peter T., Sinnwell, Jason P., Tang, Xiaojia, Thompson, Kevin J., McLaughlin, Sarah A., Moreno-Aspitia, Alvaro, Copland, John A, Northfelt, Donald W., Gray, Richard J., Hunt, Katie, Conners, Amy, Weinshilboum, Richard, Wang, Liewei, Boughey, Judy C.
Publicado 2017

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

por Chumsri, Saranya, Li, Zhuo, Serie, Daniel J., Norton, Nadine, Mashadi-Hossein, Afshin, Tenner, Kathleen, Brauer, Heather Ann, Warren, Sarah, Danaher, Patrick, Colon-Otero, Gerardo, Partridge, Ann H., Carey, Lisa A., Hilbers, Florentine, Van Dooren, Veerle, Holmes, Eileen, Di Cosimo, Serena, Werner, Olena, Huober, Jens Bodo, Dueck, Amylou C., Sotiriou, Christos, Saura, Cristina, Moreno-Aspitia, Alvaro, Knutson, Keith L., Perez, Edith A., Thompson, E. Aubrey
Publicado 2022